Opinion Statement
Alcohol has long been associated with pancreatitis. Although first described more than three decades ago, smoking has been widely accepted as an important risk factor for all forms of pancreatitis only in the past few years. Empiric data has confirmed smoking as an independent and dose-dependent risk for both acute and chronic pancreatitis. Smoking also increases the risk of recurrences and progression of established chronic pancreatitis. The effects of smoking are enhanced in the presence of alcohol consumption. Indirect evidence suggests that smoking cessation may be beneficial in preventing disease progression. Smoking cessation can therefore be an important strategy for primary as well as secondary prevention of pancreatitis. Therefore, in addition to alcohol, physicians should routinely counsel patients for the benefits of smoking cessation. The mechanisms through which cigarette smoke triggers pathological cellular events, resulting in pancreatitis, are unresolved. Although cigarette smoke contains greater than 4000 compounds, principally nicotine and the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) have been broadly studied with regard to pancreatic diseases. Both nicotine and NNK have been shown to induce morphological changes in the pancreas consistent with those seen in pancreatitis. Furthermore, nicotine affects pancreatic secretion and NNK induces premature zymogen activation, two well-known features of pancreatitis. These cigarette toxins may mediate both pro- and anti-inflammatory pathways and can induce changes in pancreatic acinar cell function at the level of transcription, leading to conditions such as thiamin deficiency and mitochondrial dysfunction. Such circumstances could leave the pancreas prone to the development of pancreatitis. This review summarizes relevant research findings and focuses on the epidemiologic links between smoking and pancreatitis, and the cellular pathways that may be significant in induction and evolution of smoking-related pancreatitis.
Similar content being viewed by others
References and Recommended Reading
Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143:1179–1187.e1171–1173.
Mullady DK, Yadav D, Amann ST, O’Connell MR, Barmada MM, Elta GH, et al. Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. Gut. 2011;60:77–84.
Yadav D, Timmons L, Benson JT, Dierkhising RA, Chari ST. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. [Erratum appears in Am J Gastroenterol. 2011 Dec;106(12):2209]. American Journal of Gastroenterology 2011, 106:2192–2199.
Cote GA, Yadav D, Slivka A, Hawes RH, Anderson MA, Burton FR, et al. Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2011;9:266–73. quiz e227.
Yadav D, Hawes RH, Brand RE, Anderson MA, Money ME, Banks PA, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis.[Erratum appears in Arch Intern Med. 2011 Apr 11;171(7):710]. Archives of Internal Medicine 2009, 169:1035–1045.
Bourliere M, Barthet M, Berthezene P, Durbec JP, Sarles H. Is tobacco a risk factor for chronic pancreatitis and alcoholic cirrhosis? Gut. 1991;32:1392–5.
Yen S, Hsieh CC, MacMahon B. Consumption of alcohol and tobacco and other risk factors for pancreatitis. Am J Epidemiol. 1982;116:407–14.
Lowenfels AB, Zwemer FL, Jhangiani S, Pitchumoni CS. Pancreatitis in a native American Indian population. Pancreas. 1987;2:694–7.
Haber PS, Wilson JS, Pirola RC. Smoking and alcoholic pancreatitis. Pancreas. 1993;8:568–72.
Levy P, Mathurin P, Roqueplo A, Rueff B, Bernades P. A multidimensional case-control study of dietary, alcohol, and tobacco habits in alcoholic men with chronic pancreatitis. Pancreas. 1995;10:231–8.
Lin Y, Tamakoshi A, Hayakawa T, Ogawa M, Ohno Y. Cigarette smoking as a risk factor for chronic pancreatitis: a case-control study in Japan. Research Committee on Intractable Pancreatic Diseases. Pancreas. 2000;21:109–14.
Rothenbacher D, Low M, Hardt PD, Klor HU, Ziegler H, Brenner H. Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population-based study. Scand J Gastroenterol. 2005;40:697–704.
Talamini G, Bassi C, Falconi M, Frulloni L, Di Francesco V, Vaona B, et al. Cigarette smoking: an independent risk factor in alcoholic pancreatitis. Pancreas. 1996;12:131–7.
Yadav D, Eigenbrodt ML, Briggs MJ, Williams DK, Wiseman EJ. Pancreatitis: prevalence and risk factors among male veterans in a detoxification program. Pancreas. 2007;34:390–8.
Morton C, Klatsky AL, Udaltsova N. Smoking, coffee, and pancreatitis. Am J Gastroenterol. 2004;99:731–8.
Tolstrup JS, Kristiansen L, Becker U, Gronbaek M. Smoking and risk of acute and chronic pancreatitis among women and men: a population-based cohort study. [Erratum appears in Arch Intern Med. 2010 Sep 13;170(16):1424]. Archives of Internal Medicine 2009, 169:603–609.
Andriulli A, Botteri E, Almasio PL, Vantini I, Uomo G, Maisonneuve P, et al. Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis. Pancreas. 2010;39:1205–10. This meta-analysis summarizes the data from published observational studies on the association between smoking and chronic pancreatitis.
Kristiansen L, Gronbaek M, Becker U, Tolstrup JS. Risk of pancreatitis according to alcohol drinking habits: a population-based cohort study. Am J Epidemiol. 2008;168:932–7.
Yang H, Wang L, Shi YH, Sui GT, Wu YF, Lu XQ, et al. Risk factors of acute pancreatitis in the elderly Chinese population: a population-based cross-sectional study. J Dig Dis. 2014;15:501–7.
Blomgren KB, Sundstrom A, Steineck G, Genell S, Sjostedt S, Wiholm BE. A Swedish case-control network for studies of drug-induced morbidity—acute pancreatitis. Eur J Clin Pharmacol. 2002;58:275–83.
Eland IA, Sundstrom A, Velo GP, Andersen M, Sturkenboom MC, Langman MJ, et al. Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis (EDIP). Scand J Gastroenterol. 2006;41:1484–90.
Ozhan G, Yanar HT, Ertekin C, Alpertunga B. Polymorphisms in tumour necrosis factor alpha (TNFalpha) gene in patients with acute pancreatitis. Mediat Inflamm. 2010;2010:482950.
DiMagno MJ, Spaete JP, Ballard DD, Wamsteker EJ, Saini SD. Risk models for post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP): smoking and chronic liver disease are predictors of protection against PEP. Pancreas. 2013;42:996–1003.
Gonzalez-Perez A, Schlienger RG, Rodriguez LA. Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study. Diabetes Care. 2010;33:2580–5.
Sjoberg Bexelius T, Garcia Rodriguez LA, Lindblad M. Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study. Pancreatology. 2009;9:786–92.
Lindkvist B, Appelros S, Manjer J, Berglund G, Borgstrom A. A prospective cohort study of smoking in acute pancreatitis. Pancreatology. 2008;8:63–70.
Sadr-Azodi O, Andren-Sandberg A, Orsini N, Wolk A. Cigarette smoking, smoking cessation and acute pancreatitis: a prospective population-based study. Gut. 2012;61:262–7.
Sun X, Huang X, Zhao R, Chen B, Xie Q. Meta-analysis: tobacco smoking may enhance the risk of acute pancreatitis. Pancreatology. Published online on March 11, 2015. This meta analysis summarizes the results of published studies on the association between smoking and acute pancreatitis.
Daeppen JB, Smith TL, Danko GP, Gordon L, Landi NA, Nurnberger Jr JI, et al. Clinical correlates of cigarette smoking and nicotine dependence in alcohol-dependent men and women. The Collaborative Study Group on the Genetics of Alcoholism. Alcohol Alcohol. 2000;35:171–5.
Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61:1107–15.
Maisonneuve P, Lowenfels AB, Mullhaupt B, Cavallini G, Lankisch PG, Andersen JR, et al. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut. 2005;54:510–4.
Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144:1252–61.
Yadav D, Whitcomb DC. The role of alcohol and smoking in pancreatitis. Nat Rev Gastroenterol Hepatol. 2010;7:131–45.
Lankisch PG, Breuer N, Bruns A, Weber-Dany B, Lowenfels AB, Maisonneuve P. Natural history of acute pancreatitis: a long-term population-based study. Am J Gastroenterol. 2009;104:2797–805. quiz 2806.
Yadav D, O’Connell M, Papachristou GI. Natural history following the first attack of acute pancreatitis. Am J Gastroenterol. 2012;107:1096–103.
Maisonneuve P, Frulloni L, Mullhaupt B, Faitini K, Cavallini G, Lowenfels AB, et al. Impact of smoking on patients with idiopathic chronic pancreatitis. Pancreas. 2006;33:163–8.
Imoto M, DiMagno EP. Cigarette smoking increases the risk of pancreatic calcification in late-onset but not early-onset idiopathic chronic pancreatitis. Pancreas. 2000;21:115–9.
van Geenen EJ, Smits MM, Schreuder TC, van der Peet DL, Bloemena E, Mulder CJ. Smoking is related to pancreatic fibrosis in humans. Am J Gastroenterol. 2011;106:1161–6. quiz 1167.
Petrone MC, Arcidiacono PG, Perri F, Carrara S, Boemo C, Testoni PA. Chronic pancreatitis-like changes detected by endoscopic ultrasound in subjects without signs of pancreatic disease: do these indicate age-related changes, effects of xenobiotics, or early chronic pancreatitis? Pancreatology. 2010;10:597–602.
Kadiyala V, Lee LS, Banks PA, Suleiman S, Paulo JA, Wang W, et al. Cigarette smoking impairs pancreatic duct cell bicarbonate secretion. Jop: J Pancreas [Electronic Resource]. 2013;14:31–8.
Anderson KE, Hammons GJ, Kadlubar FF, Potter JD, Kaderlik KR, Ilett KF, et al. Metabolic activation of aromatic amines by human pancreas. Carcinogenesis. 1997;18:1085–92.
LaRusch J, Lozano-Leon A, Stello K, Moore A, Muddana V, O’Connell M, et al. The common chymotrypsinogen C (CTRC) variant G60G (C.180T) increases risk of chronic pancreatitis but not recurrent acute pancreatitis in a North American population. Clin Transl Gastroenterol. 2015;6:e68.
Yadav D, Slivka A, Sherman S, Hawes RH, Anderson MA, Burton FR, et al. Smoking is underrecognized as a risk factor for chronic pancreatitis. Pancreatol: Off J Int Assoc Pancreatol. 2010;10:713–9.
Edderkaoui M, Thrower E. Smoking and pancreatic disease. J Cancer Ther. 2013;4:34–40.
Chowdhury P. An exploratory study on the development of an animal model of acute pancreatitis following nicotine exposure. Tob Induc Dis. 2003;1:213–7.
Chowdhury P, Ami M, Hosotani R, Rayford PL. Meal-stimulated exocrine pancreatic secretion and release of GI peptides in normal and nicotine-treated rats. Regul Pept. 1991;33:11–20.
Chowdhury P, Bose C, Udupa KB. Nicotine-induced proliferation of isolated rat pancreatic acinar cells: effect on cell signalling and function. Cell Prolif. 2007;40:125–41.
Chowdhury P, Doi R, Chang LW, Rayford PL. Tissue distribution of [3H]-nicotine in rats. Biomed Environ Sci. 1993;6:59–64.
Chowdhury P, Doi R, Tangoku A, Rayford PL. Structural and functional changes of rat exocrine pancreas exposed to nicotine. Int J Pancreatol. 1995;18:257–64.
Chowdhury P, Hosotani R, Chang L, Rayford PL. Metabolic and pathologic effects of nicotine on gastrointestinal tract and pancreas of rats. Pancreas. 1990;5:222–9.
Chowdhury P, Hosotani R, Rayford PL. Weight loss and altered circulating GI peptide levels of rats exposed chronically to nicotine. Pharmacol Biochem Behav. 1989;33:591–4.
Chowdhury P, Hosotani R, Rayford PL. Inhibition of CCK or carbachol-stimulated amylase release by nicotine. Life Sci. 1989;45:2163–8.
Chowdhury P, Inoue K, Rayford PL. Effect of nicotine on basal and bombesin stimulated canine plasma levels of gastrin, cholecystokinin and pancreatic polypeptide. Peptides. 1985;6:127–32.
Chowdhury P, MacLeod S, Udupa KB, Rayford PL. Pathophysiological effects of nicotine on the pancreas: an update. Exp Biol Med (Maywood). 2002;227:445–54.
Chowdhury P, Rayford PL, Chang LW. Induction of pancreatic acinar pathology via inhalation of nicotine. Proc Soc Exp Biol Med. 1992;201:159–64.
Chowdhury P, Udupa KB. Nicotine as a mitogenic stimulus for pancreatic acinar cell proliferation. World J Gastroenterol. 2006;12:7428–32.
Chowdhury P, Udupa KB. Effect of nicotine on exocytotic pancreatic secretory response: role of calcium signaling. Tob Induc Dis. 2013;11:1.
Chowdhury P, Walker A. A cell-based approach to study changes in the pancreas following nicotine exposure in an animal model of injury. Langenbecks Arch Surg. 2008;393:547–55.
Hartwig W, Werner J, Ryschich E, Mayer H, Schmidt J, Gebhard MM, et al. Cigarette smoke enhances ethanol-induced pancreatic injury. Pancreas. 2000;21:272–8.
Lindkvist B, Wierup N, Sundler F, Borgstrom A. Long-term nicotine exposure causes increased concentrations of trypsinogens and amylase in pancreatic extracts in the rat. Pancreas. 2008;37:288–94.
Wittel UA, Pandey KK, Andrianifahanana M, Johansson SL, Cullen DM, Akhter MP, et al. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol. 2006;101:148–59.
Wittel UA, Singh AP, Henley BJ, Andrianifahanana M, Akhter MP, Cullen DM, et al. Cigarette smoke-induced differential expression of the genes involved in exocrine function of the rat pancreas. Pancreas. 2006;33:364–70.
Al-Wadei HA, Schuller HM. Nicotinic receptor-associated modulation of stimulatory and inhibitory neurotransmitters in NNK-induced adenocarcinoma of the lungs and pancreas. J Pathol. 2009;218:437–45.
Askari MD, Tsao MS, Cekanova M, Schuller HM. Ethanol and the tobacco-specific carcinogen, NNK, contribute to signaling in immortalized human pancreatic duct epithelial cells. Pancreas. 2006;33:53–62.
Rioux N, Castonguay A. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone modulation of cytokine release in U937 human macrophages. Cancer Immunol Immunother. 2001;49:663–70.
Trushin N, Leder G, El-Bayoumy K, Hoffmann D, Beger HG, Henne-Bruns D, et al. The tobacco carcinogen NNK is stereoselectively reduced by human pancreatic microsomes and cytosols. Langenbecks Arch Surg. 2008;393:571–9.
Ding YS, Zhang L, Jain RB, Jain N, Wang RY, Ashley DL, et al. Levels of tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons in mainstream smoke from different tobacco varieties. Cancer Epidemiol Biomarkers Prev. 2008;17:3366–71.
Chowdhury P, Rayford PL, Chang LW. Pathophysiological effects of nicotine on the pancreas. Proc Soc Exp Biol Med. 1998;218:168–73.
Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res. 1988;48:6912–7.
Schuller HM. Nitrosamines as nicotinic receptor ligands. Life Sci. 2007;80:2274–80.
Akopyan G, Bonavida B. Understanding tobacco smoke carcinogen NNK and lung tumorigenesis. Int J Oncol. 2006;29:745–52.
Schuller HM. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer. 2002;2:455–63.
Alexandre M, Uduman AK, Minervini S, Raoof A, Shugrue CA, Akinbiyi EO, et al. Tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone initiates and enhances pancreatitis responses. Am J Physiol Gastrointest Liver Physiol. 2012;303:G696–704. This is the first paper to describe a direct effect of a cigarette toxin (NNK) on a pancreatic acinar cell and to demonstrate initiation of pancreatitis responses via a receptor mediated mechanism (in this case, a non-neuronal nicotinic receptor).
Schuller HM, Tithof PK, Williams M, Plummer 3rd H. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res. 1999;59:4510–5.
Chaudhuri A, Kolodecik TR, Gorelick FS. Effects of increased intracellular cAMP on carbachol-stimulated zymogen activation, secretion, and injury in the pancreatic acinar cell. Am J Physiol Gastrointest Liver Physiol. 2005;288:G235–43.
Ashat M, Tashkandi N, Sreekumar B, Patel V, Chowdhury AB, Shugrue C, et al. Sa1788 tobacco toxin NNK (4-[Methylnitrosamino]-1-[3-Pyridyl]-1-Butanone) mediates zymogen activation in murine and human pancreatic acini. Gastroenterology. 2014;146:S-296.
Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov. 2005;4:673–84.
Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384–8.
van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology. 2006;130:1822–30.
Schneider L, Jabrailova B, Soliman H, Hofer S, Strobel O, Hackert T, et al. Pharmacological cholinergic stimulation as a therapeutic tool in experimental necrotizing pancreatitis. Pancreas. 2014;43:41–6.
Greer JB, Whitcomb DC. Inflammation and pancreatic cancer: an evidence-based review. Curr Opin Pharmacol. 2009;9:411–8.
Foster JR, Idle JR, Hardwick JP, Bars R, Scott P, Braganza JM. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol. 1993;169:457–63.
Srinivasan P, Subramanian VS, Said HM. Effect of the cigarette smoke component, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), on physiological and molecular parameters of thiamin uptake by pancreatic acinar cells. PLoS One. 2013;8:e78853. This is the first paper to demonstrate an effect of a cigarette toxin (NNK), at the level of transcription, in the pancreatic acinar cell. As a result, NNK reduces levels of thiamin transporters, resulting in a vitamin deficiency and subsequent mitochondrial dysfunction. Such conditions could predispose to onset of pancreatitis.
Compliance with Ethics Guidelines
Conflict of Interest
Edwin Thrower has received support from Connecticut Department of Public Health (DPH contract log # 2014-0138), National Institute on Alcohol Abuse and Alcoholism (R21 AA-020847-01) and the Department of Veterans Affairs.
Julia B. Greer has received a grant from Abbvie, Inc.
Dhiraj Yadav has received consultancy fees from Abbvie, Inc. and grant from the NIH (RO1-DK077906).
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Pancreas
Rights and permissions
About this article
Cite this article
Greer, J.B., Thrower, E. & Yadav, D. Epidemiologic and Mechanistic Associations Between Smoking and Pancreatitis. Curr Treat Options Gastro 13, 332–346 (2015). https://doi.org/10.1007/s11938-015-0056-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11938-015-0056-9